Primary immunodeficiency
Top Cited Papers
Open Access
- 11 September 2018
- journal article
- review article
- Published by Springer Science and Business Media LLC in Allergy, Asthma & Clinical Immunology
- Vol. 14 (S2), 1-12
- https://doi.org/10.1186/s13223-018-0290-5
Abstract
Primary immunodeficiency disorder (PID) refers to a large heterogeneous group of disorders that result from defects in immune system development and/or function. PIDs are broadly classified as disorders of adaptive immunity (i. e., T cell, B-cell or combined immunodeficiencies) or of innate immunity (e. g., phagocyte and complement disorders). Although the clinical manifestations of PIDs are highly variable, many disorders involve an increased susceptibility to infection. Early consultation with a clinical immunologist is essential, as timely diagnosis and treatment are imperative for preventing significant disease-associated morbidity. PIDs should be suspected in patients with: recurrent sinus or ear infections or pneumonias within a 1 year period; failure to thrive; poor response to prolonged use of antibiotics; persistent thrush or skin abscesses; or a family history of PID. Patients with multiple autoimmune diseases should also be evaluated. Diagnostic testing often involves lymphocyte proliferation assays, flow cytometry, measurement of serum immunoglobulin (Ig) levels, assessment of serum specific antibody titers in response to vaccine antigens, neutrophil function assays, stimulation assays for cytokine responses, and complement studies. The treatment of PIDs is complex and generally requires both supportive and definitive strategies. Ig replacement therapy is the mainstay of therapy for B-cell disorders, and is also an important supportive treatment for many patients with combined immunodeficiency disorders. The disorders affecting the activity of the T-cell arm of the adaptive system, such as severe combined immunodeficiency, require immune reconstitution as soon as possible. The treatment of innate immunodeficiency disorders varies depending on the type of defect, but may involve antifungal and antibiotic prophylaxis, cytokine replacement, vaccinations and bone marrow transplantation. This article provides an overview of the major categories of PIDs and strategies for the appropriate diagnosis and management of these rare disorders.Keywords
This publication has 31 references indexed in Scilit:
- Primary Immunodeficiency Diseases: An Update on the Classification from the International Union of Immunological Societies Expert Committee for Primary ImmunodeficiencyFrontiers in Immunology, 2014
- Secondary antibody deficiencyExpert Review of Clinical Immunology, 2014
- Use and interpretation of diagnostic vaccination in primary immunodeficiency: A working group report of the Basic and Clinical Immunology Interest Section of the American Academy of Allergy, Asthma & ImmunologyJournal of Allergy and Clinical Immunology, 2012
- Impact of trough IgG on pneumonia incidence in primary immunodeficiency: A meta-analysis of clinical studiesClinical Immunology, 2010
- Primary immunodeficienciesJournal of Allergy and Clinical Immunology, 2010
- Laboratory evaluation of primary immunodeficienciesJournal of Allergy and Clinical Immunology, 2010
- The Use of Immunoglobulin Therapy for Patients With Primary Immune Deficiency: An Evidence-Based Practice GuidelineTransfusion Medicine Reviews, 2010
- Late‐Onset Combined Immune Deficiency: A Subset of Common Variable Immunodeficiency with Severe T Cell DefectClinical Infectious Diseases, 2009
- Primary B Cell Immunodeficiencies: Comparisons and ContrastsAnnual Review of Immunology, 2009
- Population Prevalence of Diagnosed Primary Immunodeficiency Diseases in the United StatesJournal of Clinical Immunology, 2007